Strengthen your security stack with Microsoft Defender for Endpoint for advanced threat protection, detection, and real-time defense.
Emerging opportunities in the STAT Inhibitors market lie in targeting dysregulated STAT pathways, particularly STAT3 and STAT5, for cancers and inflammatory conditions. Novel drugs like Tvardi's ...
Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results